Severe preeclampsia Preeclampsia
Conditions
Interventions
Nifedipine was administered 3 doses within 60 minutes (i.e., 20 minutes interval). Dose of oral nifedipine was (20 mg). ,Labetalol was administered 3 doses within 60 minutes (i.e., 20 minutes interva
Active Comparator Drug,Active Comparator Drug,Active Comparator Drug
Nifedipine,Labetalol,Hydralazine
Sponsors
Local, in Arifin Achmad Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: All pregnant women with a diagnosis of severe preeclampsia. Gestational age of 28 to 34 weeks. Live fetus. Upper arm circumference 23.5 to 33 cm. Willing to participate in research. Hemoglobin level 10.5 g/dl.
Exclusion criteria
Exclusion criteria: 1. Pregnant women with severe preeclampsia with decreased consciousness. 2. Pregnant women with severe preeclampsia accompanied by complications/complications such as eclampsia, HELLP syndrome, kidney failure, or acute pulmonary oedema. 3. Pregnant women with severe preeclampsia in labor. 4. Pregnant women with severe preeclampsia who received antihypertensive therapy in the last 12 hours. 5. Pregnant women with severe preeclampsia who have a history of allergy to the trial drug. 6. Pregnant women with severe preeclampsia who have a history of asthma and heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure 6 hours Direct assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective side effect 6 hours Interview | — |
Countries
Indonesia
Contacts
Public ContactDonel Suhaimi
Fakultas Kedokteran Universitas Riau
Outcome results
None listed